RxDoctor Payments DataLook up a doctor →

David Kong

Cardiovascular Disease · Durham, NCNPI 1295819357

Payments from drug & device makers

$1,146,554in general payments, 2019–2025

Across 390 payments — averaging $2939.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Philips North America LLC$711K
  • Terumo Medical Corporation$150K
  • Novo Nordisk AS$131K
  • Chiesi USA, Inc.$124K
  • Radiometer America, Inc$15K
  • Abbott$12K
  • plus $5K from 6 others
$239,428in research payments, 2019–2025

Across 117 payments — averaging $2046.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novo Nordisk AS$239K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,146,554 in reported general payments places this provider in the 95th percentile of 727 cardiovascular disease providers in North Carolina.

See all cardiovascular disease providers in North Carolina

Medicare billing

Part B allowed, 2024
$49,491
Medicare patients
212
Services billed
369

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →